Jon M. Spanbauer's Profile Image

Jon M. Spanbauer

Direct: (312) 638-8782
Fax: (312) 638-8793

Jon has 15 years of experience litigating intellectual property disputes in district courts throughout the United States. He has represented many of the country’s largest pharmaceutical companies in complex patent cases covering a wide range of technologies, with a particular emphasis on pharmaceuticals (Hatch-Waxman litigation), medical devices, and biologics.

Jon's courtroom experience includes Markman hearings, summary judgment proceedings, months of jury and bench trial work, and appeals before the Federal Circuit. He has also represented clients in commercial litigation matters, trade secret disputes, mediation proceedings, and in licensing negotiations.

Jon has a Master of Science degree in Biological Chemistry from the University of Michigan (1997) and a law degree from the University of Wisconsin (2002).

Representative Patent Cases:

  • Nutrition 21 v. Pfizer (S.D.N.Y.): Counsel for Pfizer in litigation involving patent infringement and state law claims (trade secret misappropriation and breach of contract) concerning Pfizer’s Centrum® line of multivitamin products. After discovery, Markman and summary judgment proceedings, obtained dismissal and/or withdrawal of virtually all of the about 75 originally-asserted patent claims, and all of the state law claims. Case settled immediately before trial.
  • AstraZeneca Apotex (D. N.J): Counsel for AstraZeneca in Hatch-Waxman litigation (including a seven-week bench trial in 2012) involving patents concerning AstraZeneca’s PULMICORT RESPULES® nebulized medication for the treatment of asthma.
  • Cordis Corporation and Wyeth Abbott Laboratories (D. N.J.); Cordis Corporation and Wyeth v. Abbott Laboratories, Boston Scientific Corporation and Medtronic (D. N.J.); Boston Scientific Corporation v. Johnson & Johnson, Cordis Corporation and Wyeth (D. Del.): Counsel for patent holders Cordis and Wyeth in a series of patent infringement suits involving drug-eluting coronary stent technology.
  • The Rockefeller University and Chiron Corporation v. Centocor, Inc. and Abbott Laboratories (E.D. Tex.): Counsel for Centocor in patent infringement litigation concerning Tumor Necrosis Factor chimeric antibody technology brought against Centocor. Claims against Centocor settled.
  • Boston Scientific v. Cordis Corporation (N.D. Cal.): Counsel for Johnson & Johnson and Cordis in litigation involving nine patents concerning balloon angioplasty catheter technology. After a three-week jury trial in 2007, the jury returned a verdict finding Boston Scientific patents invalid and finding that Boston Scientific infringed a Cordis patent asserted in a counterclaim.
  • Marley Mouldings Limited Mikron Industries (N.D. Ill.): Counsel for plaintiff Marley in patent infringement suit involving processing polymer/wood fiber composite. Case settled after ruling of summary judgment of literal infringement in favor of plaintiff.